Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2010
10/20/2010EP1206554B2 Activatable recombinant neurotoxins
10/20/2010EP0959075B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
10/20/2010CN1994155B Healthy oral liquid and preparation method thereof
10/20/2010CN1977890B Chinese medicine composition and its use
10/20/2010CN1938030B Transdermal iontophoretic delivery of piperazinyl-2(3h)-benzoxazolone compounds
10/20/2010CN101868458A Isoxazolo-pyridazine derivatives
10/20/2010CN101868457A (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
10/20/2010CN101868454A Cycloalkyloxy- and heterocycloalky-loxypyridine compounds as modulators of the histamine H3 receptor
10/20/2010CN101868451A Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
10/20/2010CN101868450A Compounds of 2,3-dihydro-benzofuran
10/20/2010CN101868443A N-phenyl anthranilic acid derivatives and uses thereof
10/20/2010CN101868237A Alpha7 nAChR agonists for treating or preventing metabolic disorders
10/20/2010CN101868156A Citrulline-containing drink
10/20/2010CN101863962A Polypeptide for inhibiting enzyme digestion of beta secretase and application thereof
10/20/2010CN101863903A 1,4-dihydrobithiophene [3', 2': 5, 6] bithiapyran [4, 3-c] pyrazol-3-carboxylic acid derivative and application thereof
10/20/2010CN101863871A Total glycosides of Rhodiola rosea, medical application and preparation method thereof
10/20/2010CN101863839A N-3-aramid-5-cyclopropane spiro hydantoin derivative, preparation method and application thereof
10/20/2010CN101862453A New self emulsifying drug delivery system
10/20/2010CN101862447A Natto kinase composition and preparation method thereof
10/20/2010CN101862427A Oral liquid for treating panasthenia and preparation method thereof
10/20/2010CN101862422A Chinese medicinal composition for removing internal damp-heat and application thereof in relieving alcoholism and preserving health
10/20/2010CN101862418A Rehabilitation capsule of drug-taking patient
10/20/2010CN101862382A Pearl health care product for improving sleeping
10/20/2010CN101862363A General ginsenoside primary osmotic pump tablet and preparation method thereof
10/20/2010CN101862332A Composition for preventing human body injuries by excessive consumption of alcohol and preparation method and application thereof
10/20/2010CN101862331A New use of methyl liensinine
10/20/2010CN101862317A Pregabalin derivatives for the treatment of fibromyalgia and other disorders
10/20/2010CN101862312A New application of 6-gingerol
10/20/2010CN101862310A Transdermal system for varenicline
10/20/2010CN101862292A Ibuprofen suspension
10/20/2010CN101284054B Externally-applied drug for treating insomnia
10/20/2010CN101259257B Preparation of Chinese medicine for treating facial neuritis
10/19/2010US7816539 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816376 Use as excitatory amino acid antagonists for combating neurodegenerative and cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's, Parkinson's or Huntington's disease, or psychoses; for example, 3-[4-(3,4-methylenedioxybenzyl)piperidino]-N-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propionamide
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816358 Pharmaceutical formulations comprising N,N′-disubstituted piperazine compounds
10/19/2010US7816350 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
10/19/2010US7815938 Film coating
10/19/2010US7815937 Liquiflash particles and an excipient mass; friability of less than 1%; need for conventional super disintegrant and having a friability of less than 1%; no need for conventional superdisintegrant
10/19/2010US7815932 drug layer, support layer insoluble in water comprising ethyl cellulose and hydroxypropyl methylcellulose, backing on support layer, wherein drug layer consists of fentanyl or salt as active ingredient, methyl vinyl ether-maleic anhydride copolymer as adhesive, hydroxypropylcellulose; easily removed
10/19/2010CA2525245C Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors
10/19/2010CA2469346C Substituted 2-pyrrolidin-2-yl-1h-indole derivatives for treatment of migraine
10/19/2010CA2464367C Bicyclic compounds
10/19/2010CA2463284C Pyrimidine compounds and pharmaceutical compositions containing the compounds
10/19/2010CA2451422C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
10/19/2010CA2448089C Thiolalkyl benzoic acid derivatives
10/19/2010CA2439791C Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
10/19/2010CA2436526C Heterocyclic sulfonamide inhibitors of beta amyloid production
10/19/2010CA2429496C Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
10/19/2010CA2325803C Novel omega conotoxin peptides
10/19/2010CA2321455C Indole-3-propionic acids, salts and esters thereof used as medicaments
10/19/2010CA2214338C Use of .alpha.1l agonists for treating urinary incontinence
10/14/2010WO2010118419A2 Novel anti-aging agents and methods to identify them
10/14/2010WO2010118405A2 Compositions and methods for reducing hangover symptoms
10/14/2010WO2010118263A1 Single-nucleotide polymorphism (snp) targeting therapies for the treatment of huntington's disease
10/14/2010WO2010118015A1 Control of concentric tubing direction
10/14/2010WO2010117926A1 Substituted triazolopyridines and analogs thereof
10/14/2010WO2010117787A2 Inhibiting eph b-3 kinase
10/14/2010WO2010117727A2 Phenserine and posiphen for treating neuropsychiatric and neurodegenerative conditions
10/14/2010WO2010117079A1 Neuronal differentiation-inducing peptide and use thereof
10/14/2010WO2010117078A1 Neuronal differentiation-inducing peptide and use thereof
10/14/2010WO2010117055A1 Polypeptide having selective inhibitory activity on protein kinase cα or η
10/14/2010WO2010117014A1 Triazine derivative
10/14/2010WO2010116834A1 Process for production of orally ingestible composition containing arabinosyl vitexin, and use of the composition
10/14/2010WO2010116673A1 Mitochondrial function-improving agent
10/14/2010WO2010116375A1 Isolated peptides for regulating apoptosis
10/14/2010WO2010115952A1 Indane derivatives
10/14/2010WO2010115724A1 Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1h-quinolin-2-one base or salts or hydrates thereof
10/14/2010WO2010115491A2 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010WO2010115342A1 SUSTAINED RELEASE COMPOSITION CONTAINING TETRAHYDROPYRIDO [4, 3-b] INDOLE DERIVATIVE AND PREPARATION METHOD OF DERIVATIVE
10/14/2010WO2010115267A1 Once-daily oral ir/cr pramipexole formulation
10/14/2010WO2010094090A3 Synucleinopathies
10/14/2010WO2010083384A9 Non-peptidyl, potent, and selective mu opioid receptor antagonists
10/14/2010WO2010062570A3 COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE
10/14/2010WO2010057104A3 Pyridoindole modulators of nmda receptor and acetylcholinesterase
10/14/2010WO2010057088A3 Pyrrolidinyl modulators of nicotinic acetylcholine receptors
10/14/2010WO2009144395A8 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
10/14/2010WO2009144394A8 Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-α]pyridine derivatives, and preparation and therapeutic use thereof
10/14/2010WO2009044019A9 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
10/14/2010WO2009044018A9 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
10/14/2010US20100263065 Materials and methods for gene mediated therapy of psychiatric disorders
10/14/2010US20100263063 Mouse models with enhanced essential tremor and preparation method thereof
10/14/2010US20100263062 Methods for screening and compounds that protect against amyloid diseases
10/14/2010US20100261797 New polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide
10/14/2010US20100261791 Compositions and Methods for Improving or Preserving Brain Function
10/14/2010US20100261788 Inhibition of Bid-Induced Cell-Death Using Small Organic Molecules
10/14/2010US20100261786 Prediction of sleep parameter and response to sleep-inducing compound based on per3 vntr genotype
10/14/2010US20100261783 Cruciferous 3h-1,2-dithiole-3-thione (d3t) and methods of protecting against cell injury
10/14/2010US20100261775 Polymorphic form of duloxetine hydrochloride
10/14/2010US20100261773 3.3.0 BICYCLIC GlyT1 INHIBITORS AND METHODS OF MAKING AND USING SAME
10/14/2010US20100261772 Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators
10/14/2010US20100261768 Bioavailable Compositions of Amorphous Alpha-(N-Sulfonamido)Acetamide Compound
10/14/2010US20100261765 Mineralocorticoid receptor modulators
10/14/2010US20100261753 Methods for preventing and/or treating degenerative disorders of the central nervous system
10/14/2010US20100261752 5-ht4 receptor agonist compounds for treatment of cognitive disorders
10/14/2010US20100261750 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
1 ... 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 ... 1833